2-[3-(4-Nitro-1H-pyrazol-1-yl)propyl]-2,3-dihydro-1H-isoindole-1,3-dione

Catalog No. :
ACMURH093
CAS No. :
1006572-22-0
Molecular Formula :
C14H12N4O4
Molecular Weight :
300.27

IUPAC Name:2-(3-(4-nitro-1H-pyrazol-1-yl)propyl)isoindoline-1,3-dione

2-[3-(4-Nitro-1H-pyrazol-1-yl)propyl]-2,3-dihydro-1H-isoindole-1,3-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[3-(4-Nitro-1H-pyrazol-1-yl)propyl]-2,3-dihydro-1H-isoindole-1,3-dione
IUPAC Name2-(3-(4-nitro-1H-pyrazol-1-yl)propyl)isoindoline-1,3-dione
Molecular FormulaC14H12N4O4
Molecular Weight300.27
SMILESO=C1N(CCCN2N=CC([N+]([O-])=O)=C2)C(C3=C1C=CC=C3)=O
InChI KeyRBFCJTOXMNXSFJ-UHFFFAOYSA-N
Synonym2-[3-(4-nitro-1H-pyrazol-1-yl)propyl]-2,3-dihydro-1H-isoindole-1,3-dione;2-[3-(4-Nitro-1H-pyrazol-1-yl)propyl]-1H-isoindole-1,3(2H)-dione;1H-Isoindole-1,3(2H)-dione, 2-[3-(4-nitro-1H-pyrazol-1-yl)propyl]-
CAS No.1006572-22-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMURH093 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEHVK706 route compound structure diagram
    ACEHVK7065460-29-7 In Stock
  2. Plus
  3. ACNIUP534 route compound structure diagram
    ACNIUP5342075-46-9 In Stock
  4. Then
  5. ACMURH093 route product structure diagram
    ACMURH0931006572-22-0
Inquiry

2. ACMURH093 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJDOI249 route compound structure diagram
    ACJDOI2491074-82-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMURH093 route product structure diagram
    ACMURH0931006572-22-0
Inquiry

Comments (0)